5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.20▼ | 1.20▼ | 1.20▼ | 1.22▼ | 1.15▲ |
MA10 | 1.20▼ | 1.21▼ | 1.20▼ | 1.17▲ | 1.17▲ |
MA20 | 1.20▼ | 1.21▼ | 1.22▼ | 1.18▲ | 1.20▼ |
MA50 | 1.21▼ | 1.23▼ | 1.19▼ | 1.18▲ | 2.03▼ |
MA100 | 1.25▼ | 1.17▲ | 1.18▲ | 1.25▼ | 4.52▼ |
MA200 | 1.21▼ | 1.19▼ | 1.18▲ | 1.62▼ | 23.40▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.002▼ | -0.007▼ | 0.007▲ | 0.090▲ |
RSI | 43.959▼ | 42.454▼ | 45.232▼ | 51.661▲ | 43.248▼ |
STOCH | 48.611 | 37.037 | 32.176 | 67.940 | 26.382 |
WILL %R | -75.000▼ | -77.778▼ | -84.615▼ | -40.000 | -60.165 |
CCI | -50.000 | -139.453▼ | -119.192▼ | 52.448 | 50.159 |
MA | $BCLI Price Crossed Below MA(7) | Set Alert |
Tuesday, July 08, 2025 04:00 AM
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today acknowledged that the U.S. Food and Drug Administration's ...
|
Monday, July 07, 2025 08:12 AM
BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Citizen’s Petition Filed Requesting FDA Approve NurOwn™ On July 3, 2025, a Citizen’s Petition was filed with the U.S. Food and Drug ...
|
Tuesday, May 27, 2025 10:27 AM
By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Receives Regulatory Clearance to Initiate Phase 3b Trial of NurOwn® in ALS On May 19, 2025, BrainStorm Cell ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
11/07/25 | 1.23 | 1.2518 | 1.18 | 1.20 | 251,799 |
10/07/25 | 1.255 | 1.255 | 1.18 | 1.22 | 293,662 |
09/07/25 | 1.28 | 1.31 | 1.2301 | 1.24 | 442,814 |
08/07/25 | 1.20 | 1.32 | 1.15 | 1.31 | 2,136,753 |
07/07/25 | 1.16 | 1.19 | 1.13 | 1.14 | 153,600 |
03/07/25 | 1.14 | 1.19 | 1.14 | 1.16 | 98,008 |
02/07/25 | 1.11 | 1.17 | 1.09 | 1.17 | 282,824 |
01/07/25 | 1.12 | 1.15 | 1.0901 | 1.11 | 212,972 |
30/06/25 | 1.06 | 1.15 | 1.05 | 1.12 | 247,478 |
27/06/25 | 1.08 | 1.10 | 1.02 | 1.06 | 422,213 |
|
|
||||
|
|
||||
|
|